Neuromodulation for Drug-Resistant Epilepsy in Children
Annals of Child Neurology · 01.07.2026 · 34 (3) · 181-191
DOI: 10.26815/acn.2026.01515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Child Neurology, erschienen am 01.07.2026. Verfasst von Hyoung Won Choi. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Neuromodulation has emerged as a promising therapeutic strategy for drug-resistant epilepsy. For several modalities, long-term follow-up data are now available in adults; however, high-level evidence supporting their use in children remains limited. Vagus nerve stimulation has long been used to treat drug-resistant epilepsy in both adults and children. In contrast, responsive neurostimulation and deep brain stimulation are not formally approved for pediatric use worldwide, although they are offered off-label in select healthcare systems. This narrative review summarizes the current literature on neuromodulation for pediatric epilepsy, focusing on mechanisms of action, efficacy, patient selection, and safety.
Zitieren
APA
Choi, H. W. (2026). Neuromodulation for Drug-Resistant Epilepsy in Children. Annals of Child Neurology, 34(3), 181-191. https://doi.org/10.26815/acn.2026.01515
Vancouver
Choi HW. Neuromodulation for Drug-Resistant Epilepsy in Children. Annals of Child Neurology. 2026;34(3):181-191. doi:10.26815/acn.2026.01515
BibTeX
@article{Choi2026,
author = {Choi, Hyoung Won},
title = {Neuromodulation for Drug-Resistant Epilepsy in Children},
journal = {Annals of Child Neurology},
year = {2026},
volume = {34},
number = {3},
pages = {181--191},
doi = {10.26815/acn.2026.01515}
}
EUVIMED